Crewe Advisors LLC Has $165,000 Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Crewe Advisors LLC cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.9% in the second quarter, HoldingsChannel reports. The institutional investor owned 371 shares of the medical equipment provider’s stock after selling 32 shares during the quarter. Crewe Advisors LLC’s holdings in Intuitive Surgical were worth $165,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Creekmur Asset Management LLC lifted its position in shares of Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares in the last quarter. Ridgewood Investments LLC acquired a new position in Intuitive Surgical during the 2nd quarter worth $26,000. Able Wealth Management LLC bought a new position in Intuitive Surgical in the 4th quarter valued at $28,000. Delos Wealth Advisors LLC increased its stake in shares of Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 57 shares during the period. Finally, MeadowBrook Investment Advisors LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter worth $30,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Up 1.1 %

ISRG traded up $5.46 during trading hours on Friday, hitting $492.63. 1,097,672 shares of the company’s stock were exchanged, compared to its average volume of 1,521,578. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $493.97. The stock’s 50-day moving average is $453.49 and its two-hundred day moving average is $413.69. The stock has a market cap of $174.74 billion, a price-to-earnings ratio of 88.92, a PEG ratio of 4.97 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. The firm had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The business’s revenue was up 14.5% compared to the same quarter last year. During the same period last year, the company earned $1.18 earnings per share. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other news, Director Craig H. Barratt sold 2,496 shares of the firm’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $402.89, for a total transaction of $1,005,613.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, Director Craig H. Barratt sold 2,496 shares of the business’s stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $402.89, for a total value of $1,005,613.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 239 shares of the stock in a transaction on Monday, June 10th. The stock was sold at an average price of $416.60, for a total value of $99,567.40. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,293,799.60. The disclosure for this sale can be found here. In the last three months, insiders sold 55,552 shares of company stock worth $26,281,657. 0.90% of the stock is owned by company insiders.

Analyst Ratings Changes

Several brokerages have recently issued reports on ISRG. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their target price for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Robert W. Baird lifted their target price on shares of Intuitive Surgical from $487.00 to $503.00 and gave the stock an “outperform” rating in a report on Friday, July 19th. The Goldman Sachs Group began coverage on Intuitive Surgical in a research report on Thursday, May 30th. They issued a “buy” rating and a $500.00 price target on the stock. Morgan Stanley upped their price objective on Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a report on Monday, July 15th. Finally, Barclays raised their target price on Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a report on Thursday, July 18th. Six analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $446.45.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.